The past, present and future of HIV-vaccine development: a critical view
- 7 January 2002
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (1) , 36-46
- https://doi.org/10.1016/s1359-6446(01)02081-5
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- In vitro correlates of HIV-2-mediated HIV-1 protectionProceedings of the National Academy of Sciences, 2000
- Antibody and Virus: Binding and NeutralizationVirology, 2000
- Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infectionAIDS, 1997
- Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive InfectionThe Journal of Infectious Diseases, 1997
- A vaccine for HIV type 1: The antibody perspectiveProceedings of the National Academy of Sciences, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Correlates of protection in HIV infection and the progression of HIV infection to AIDSImmunology Letters, 1996
- Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody LevelsThe Journal of Infectious Diseases, 1995
- The immunological principles of vaccinationThe Lancet, 1990
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983